HIV & AIDS

Long acting HIV drugs to be developed

HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of 'pill fatigue'.

Neuroscience

HIV infection linked to lower multiple sclerosis risk

HIV infection is linked to a significantly lower risk of developing multiple sclerosis (MS), indicates observational research published online in the Journal of Neurology Neurosurgery & Psychiatry.

HIV & AIDS

More bad news in fight against persistent HIV reservoirs

July has been a particularly trying month for HIV/AIDS researchers as they mourned the loss of colleagues killed in a militant attack and received new reports of the virus' remarkable tenacity.

HIV & AIDS

AIDS cure: Study sees advance for 'kick and kill' strategy

The elusive quest for an HIV cure received a boost at the world AIDS conference Tuesday as scientists said they had forced the virus out of a hiding place where it had lurked after being suppressed by drugs.

HIV & AIDS

Risk of birth defects small with HIV drugs

The risks of birth defects in children exposed to antiretroviral drugs in utero are small when considering the clear benefit of preventing mother-to-child transmission of HIV but where there are safe and effective alternatives, ...

HIV & AIDS

Dealing with HIV as a chronic disease in Africa

Since 2004, the number of patients on antiretroviral drugs in Sub-Saharan Africa has increased 24 times, to 6.9 million*. HIV has become a chronic disease. A lifelong strict adherence to treatment is necessary. Health systems ...

page 11 from 24